» Articles » PMID: 15723046

Directed Evolution of Human T-cell Receptors with Picomolar Affinities by Phage Display

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2005 Feb 22
PMID 15723046
Citations 250
Authors
Affiliations
Soon will be listed here.
Abstract

Peptides derived from almost all proteins, including disease-associated proteins, can be presented on the cell surface as peptide-human leukocyte antigen (pHLA) complexes. T cells specifically recognize pHLA with their clonally rearranged T-cell receptors (TCRs), whose natural affinities are limited to approximately 1-100 muM. Here we describe the display of ten different human TCRs on the surface of bacteriophage, stabilized by a nonnative interchain disulfide bond. We report the directed evolution of high-affinity TCRs specific for two different pHLAs: the human T-cell lymphotropic virus type 1 (HTLV-1) tax(11-19) peptide-HLA-A(*)0201 complex and the NY-ESO-1(157-165) tumor-associated peptide antigen-HLA-A(*)0201 complex, with affinities of up to 2.5 nM and 26 pM, respectively, and we demonstrate their high specificity and sensitivity for targeting of cell-surface pHLAs.

Citing Articles

TCR catch bonds nonlinearly control CD8 cooperation to shape T cell specificity.

Qin R, Zhang Y, Shi J, Wu P, An C, Li Z Cell Res. 2025; .

PMID: 40011760 DOI: 10.1038/s41422-025-01077-9.


The current landscape of optogenetics for the enhancement of adoptive T-cell therapy.

Smith G, Lee M, Jennings E, James J Discov Immunol. 2025; 4(1):kyae019.

PMID: 39959909 PMC: 11829120. DOI: 10.1093/discim/kyae019.


Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system.

Chen X, Leisegang M, Gavvovidis I, Pollack S, Lorenz F, Schumacher T Front Immunol. 2025; 15():1524629.

PMID: 39776913 PMC: 11703889. DOI: 10.3389/fimmu.2024.1524629.


design and structure of a peptide-centric TCR mimic binding module.

Householder K, Xiang X, Jude K, Deng A, Obenaus M, Wilson S bioRxiv. 2025; .

PMID: 39763827 PMC: 11702606. DOI: 10.1101/2024.12.16.628822.


Targeting cancer with precision: strategical insights into TCR-engineered T cell therapies.

Lin P, Lin Y, Mai Z, Zheng Y, Zheng J, Zhou Z Theranostics. 2025; 15(1):300-323.

PMID: 39744228 PMC: 11667231. DOI: 10.7150/thno.104594.